journal cover

Pharmacological properties of new neuroleptic compounds

Arzneimittel-Forschung

Sep 1, 1975

L CosciaA Nunziata

PMID: 25

Abstract

RMI 61 140, RMI 61 144 and RMI 61 280 are newly synthetized N-[8-R-dibenzo(b,f)oxepin-10-yl]-N'-methyl-piperazine-maleates which show interesting psychopharmacologic effects. This work contains the results of a study performed with these three compounds, in order to demonstrate their ne...read more

Mentioned in this Paper

Apokinon
Dopamine Measurement
Epinephrine Measurement
Hypothermia, Natural
Metabolic Inhibition
Motility
Negative Regulation of Receptor Activation
Metabolic Process, Cellular
Barbituric acid salt
Amphetamine
8
34
6
38
3
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Secondary Parkinson disease

Secondary Parkinson disease refers to a group of disorders that present similarly to Parkinson disease but have different etiology. Secondary Parkinson disease is caused due to the blockade of or interference in dopamine’s action in the basal ganglia. Here is the latest research.

Inotropic Agents & Heart Disease

Inotropic agents alter the force or energy of muscular contractions. Negatively inotropic agents weaken the force of muscular contractions. Positively inotropic agents increase the strength of muscular contraction. Inotropic agents are used in hospitalized patients with acute decompensated heart failure, with reduced left ventricular ejection fraction and with signs of end-organ dysfunction in the setting of a low cardiac output, or with severe systolic heart failure awaiting heart transplant to maintain hemodynamic stability or as a bridge to decision. Discover the latest research on inotrpic agents and heart diseases here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Dopamine & Behavior

Dopamine is a neurotransmitter and a hormone commonly associated with the brain's pleasure and reward system. Here is the latest research on its role in affecting and guiding human behaviour.

Collision Avoidance Behaviors

This feed focuses on collision avoidance behaviors including guiding locomotion, obstacle avoidance, and steering behaviour. Here is the latest research in this domain.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

© 2020 Meta ULC. All rights reserved

Pharmacological properties of new neuroleptic compounds

Arzneimittel-Forschung

Sep 1, 1975

L CosciaA Nunziata

PMID: 25

DOI:

Abstract

RMI 61 140, RMI 61 144 and RMI 61 280 are newly synthetized N-[8-R-dibenzo(b,f)oxepin-10-yl]-N'-methyl-piperazine-maleates which show interesting psychopharmacologic effects. This work contains the results of a study performed with these three compounds, in order to demonstrate their ne...read more

Mentioned in this Paper

Apokinon
Dopamine Measurement
Epinephrine Measurement
Hypothermia, Natural
Metabolic Inhibition
Motility
Negative Regulation of Receptor Activation
Metabolic Process, Cellular
Barbituric acid salt
Amphetamine
8
34
6
38
3

Similar Papers Found In These Feeds

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/pharmacological-properties-of-new-neuroleptic/25